Literature DB >> 15347891

Management of N0 neck in head and neck cancer: current controversies.

A A Dünne1, V G Budach, W Wagner, J A Werner.   

Abstract

Squamous cell carcinomas of the upper aerodigestive tract are characterized by a high frequency of lymphogenic metastatic spread. The neck should be included in the treatment concept because almost 25% of all patients develop occult lymph node metastases. The only exception are early carcinomas of the lower lip and the vocal cords. Since currently for high risk patients no prognostic markers or other factors for occult metastatic spread are available, treatment strategies have to include the exact knowledge of direction and extent of regional lymphatic drainage. Based on this prerequisite, concepts for selective cervical lymph node dissection in case of the clinical N0 situation were developed which may also be used for an individually optimized radiotherapy. Intensity modulated radiotherapy (IMRT) bears a high potential for an optimized irradiation in case of potential occult metastatic spread of carcinomas of the upper aerodigestive tract. Without compromising local control rates IMRT allows a considerable reduction of permanent xerostomia by sparing at least one major salivary gland. The significant scientific purpose for the N0 neck, however, will remain the identification of high-risk patients, e.g. by means of tissue and/or serum-related markers, which carry a high risk of local and distant metastases.

Entities:  

Mesh:

Year:  2004        PMID: 15347891     DOI: 10.1159/000079089

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  4 in total

Review 1.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

2.  "Conditional" neck dissection in management of laryngeal carcinoma.

Authors:  R Fiorella; V Di Nicola; M L Fiorella; C Russo
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

3.  Metastatic Squamous Cell Carcinoma of the Lower Lip: Analysis of the 5-Year Survival Rate.

Authors:  Tommaso Agostini; Giuseppe Spinelli; Francesco Arcuri; Raffaella Perello
Journal:  Arch Craniofac Surg       Date:  2017-06-26

4.  Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Georgina Juniper; Jaqueline Pei; Quan Zhou; Guolan Lu; Yu-Jin Lee; Kimberly Ramos; Andrei H Iagaru; Fred M Baik; Alexander D Colevas; Brock A Martin; Eben L Rosenthal
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.